Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Jobs Taking Leave from Apple – Analyst Blog

Zacks Market Commentaries (January 14th, 2009) Writes:

It has been reported that Steve Jobs, CEO and co-founder of Apple Inc. (AAPL) will take a 6-month leave of absence from his responsibilities at Apple.

His health has been a matter of concern for some time, and conjecture about it has had an impact on the stock price. His hormone deficiency is apparently more serious than previously indicated.

Apple is a large company. Its strategies and "road map" have been in place for some time. Its management has depth, since Steve Jobs has not been the COO for many years. I would not expect any significant impact on revenue or profits due to his absence.

The company has prospered with new products every 5 or 6 years. Since the iPhone is two years old we would not have expected a new direction from Apple until 2010.

By then we should know more about his health.

Read the full analyst report on

...
More »

Posted in Stocks to Watch | No Comments »

Æterna Zentaris Blazes A New Frontier

Mike Havrilla (July 6th, 2007) Writes:

A good balance sheet and a couple of of late-stage hormone therapy products underlie recently appointed CEO Dr. David Mazzo’s enthusiasm for the future prospects of the 16-year-old, Quebec-based biopharmaceutical firm Æterna Zentaris

More »

Tags for this Post:
Abbott Lab, AEterna Zentaris, American Urological Association, Astrazeneca, benign prostatic hyperplasia, Biopharmaceutical, Biopharmaceuticals, Biotech, biotech, Breast Cancer, Canada, cancer, Cancers, Chemicals, Chemotherapy, cutaneous leishmaniasis, David Mazzo, endometriosis, Europe, Flomax, hormone deficiency, hormone therapy products, India, Japan, late-stage hormone therapy products, Lung Cancer, Lupron Depot, Lymphoma, marketed product, marketed products, multiple myeloma, Nippon Kayaku, North America, nutraceuticals, obesity, parasitic disease, Prostate Cancer, Quebec, Richard Lewis Communications, sarcoma, Shionogi, Solvay, Solvay Pharmaceuticals, therapy for multiple cancer, treatment of benign prostatic hyperplasia, treatment of lower urinary tract symptoms, treatment of obesity, treatment of prostate cancer, tumors, United States, USD, Æterna Zentaris

Posted in Biotech | No Comments »


Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.